Summary.-In an experiment involving 950 mice with a normal lifespan of 2-3 years, in laboratory conditions, regular benzpyrene application to the skin was started at 10, 25, 40 or 55 weeks of age. The incidence rate of malignant epithelial tumours among the survivors in each group increased steeply with time. This increase was associated directly with duration of exposure but, given duration, was independent of age at the start of exposure, as were the growth rates of already established tumours.
Summary.-In an experiment involving 950 mice with a normal lifespan of 2-3 years, in laboratory conditions, regular benzpyrene application to the skin was started at 10, 25, 40 or 55 weeks of age. The incidence rate of malignant epithelial tumours among the survivors in each group increased steeply with time. This increase was associated directly with duration of exposure but, given duration, was independent of age at the start of exposure, as were the growth rates of already established tumours.
In our experiment, although age per se was irrelevant, the cancer incidence rate increased approximately as a power of the duration of exposure to benzpyrene. This shows that the observed approximate power-law increase of most human adult cancer incidence rates with age could exist merely because age equals duration of exposure to background and spontaneous carcinogenic stimuli. Thus, no intrinsic effects of ageing (such as failing immunological surveillance or age related hormonal changes) whatever need be postulated to explain the vast increases in old age of the incidence rates of such human cancers. This result can greatly simplify speculation about mechanisms of carcinogenesis. THE STRONGEST determinant of cancer incidence rates* in man appears to be age. The probability that a man will develop cancer in the next 5 years is one in 14 if he is 65, but only one in 700 if he is 25 (figures for Birmingham, U.K., from Doll, Muir and Waterhouse, 1970) . This relative risk is 50 to one, and differences in cancer incidence rates between young adults and old adults of this order of magnitude are found in many species other than man. In countries with adequate cancer registries, total cancer incidence can be separated into age-specific incidence rates for each site, and between the ages of 25 and 64 many of these separate rates increase approximately as the fourth, fifth or sixth power of age.
In this paper, we describe an attempt to determine experimentally whether these marked increases with age arise because unreversed effects of continued exposure to carcinogens accumulate with time or whether they arise because ageing affects the carcinogenic process in other ways.
Local multistage model
There is evidence that the change from the normal to the cancerous state can take place in distinct " stages ", each with its own causes. It has been shown in the case of mouse skin, for example, that exposure to a tumour initiating stimulus (which may be a subcarcinogenic dose of a skin carcinogen or one or more doses of an incomplete carcinogen, i.e. an agent which by itself is incapable of giving rise to skin cancers) may result in skin cancer formation if these is subsequent exposure to a tumour promoting agent, whereas exposure to the same 2 agents in the reverse order does not result in skin cancer (Berenblum and Shubik, 1947; Roe, 1959) . Although there may be some loss of effect of exposure to a tumour initiating agent if the promotor is given a long time after the initiator (either because of repair or because of selective destruction or shedding of altered cells, Roe et al., 1970) , there is abundant evidence from studies of experimental animals or of humans exposed to occupational or other carcinogens that some increased risk of cancer development among exposed groups may persist for long periods after exposure ceases.
In this paper, we frequently consider multistage models in which each stage is an irreversible, heritable, mutation-like event suffered by particular cells, and if one cell happens to suffer a certain set of " stages " it is then able to proliferate into a recognizable cancer. Such " local multistage models " do not require systemic stages (e.g. mutations in the immune system) which affect the whole organism. Although the experiments of Berenblum and Shubik (1947) Cairns (1975) . For evidence that most malignant tumours do arise from the uncontrolled proliferation of a single stem cell see Fialkow (1974). example, Burnet (1970) has suggested that in young people immunological surveillance mechanisms might be much more efficient at eliminating changed cells before they manage the final stage, which is proliferation to form cancer, and Dilman (1971) has suggested that tumorigenesis might be promoted by hormonal changes due to age related changes in the hypothalamus. Alternatively, it may be that the kinetic rate-constants for one or more of the changes involved in carcinogenesis (some of which are presumably mutation-like events) increase with age, perhaps because stem cells have to divide increasingly frequently to maintain ageing tissues in an intact state.
Two hypotheses are therefore possible: either (Hypothesis 1), ageing (by some intrinsic mechanism) might generally have some substantially greater relevance than that suggested by the mere postulate of a local multistage model, or, secondly (Hypothesis 2), the increase in the incidence rates of many cancers with age is generally due not to any substantial intrinsic effect of ageing but rather to a steady accumulation with time (and therefore unavoidably with age) of each of several kinds of specific change in the cells of the target tissue, the kinetic rate-constants of these changes being perhaps dependent on which stages that cell has already passed through, but being otherwise approximately independent of age.
The simple local multistage model with no intrinsic effects of age predicts that an approximate power law relationship between cancer incidence and age will exist: for the childhood cancers and for certain cancers of adult life (e.g. breast cancer, testicular cancer and prostatic cancer) this relationship is not observed and so the simple local multistage model is not plausible. However, for most cancers of adult life an approximate power law relationship between incidence rate and age does exist and it is only with such cancers that we wish to be concerned. A simple local multistage model will lead to a power law relationship, and Hypothesis 2 is the " null hypothesis " which says that in general no substantial intrinsic effect of ageing exists on the induction of those cancers of adult life whose incidence rates exhibit an approximate power law increase with age. However, even a fourth-power relationship between incidence and age implies a very sharp increase indeed in old age, and this has led many authors to posit Hypothesis 1, which says that part at least of this sharp increase is due not merely to the " local multistage " accumulation of altered cells with time but to some other intrinsic effect of old age.
To distinguish between Hypotheses 1 (some intrinsic effect of ageing) and 2 (no such effect) experimentally, various approaches are possible.. Clear proof of Hypothesis 1 would be provided if an age related process which did substantially affect the incidence of many " power law " cancers could be discovered, but none ever has been. Hypothesis 1 would also be demonstrated if transplanted tissue of a particular age in syngeneic hosts of different ages showed a susceptibility to cancer induction which depended strongly on the age of the host, but this experiment has never been performed. On the assumption that cigarette smoking is the major determinant of lung cancer, we can attempt to discriminate between these hypotheses from available human data. According to Kahn (1966) , the annual lung cancer death rate per 100,000 for currently smoking males aged 55-64 is 251 for those who began to smoke before they were aged 15 and 53 for smokers who started after age 25. For currently smoking 65-75 year old males, the rates were 478 and 162 respectively. As can be seen from Table I , these 4 death rates can all be taken as proportional to duration of smoking to the fourth power. Kahn's findings can therefore be explained satisfactorily by Hypothesis 2 (i.e. the local multistage model with no intrinsic effect of age). Doll (1971a) , in a recent review article, also concluded that data for human cancer in general support Hypothesis 2. He said " it seems unlikely that age per se is a principal factor in determining the frequency ... and there is no consistent difference in the susceptibility to cancer induction when individuals are exposed to the same agent at different ages ". Nevertheless, the human data are not well controlled, the only animal experiment previously reported was small (Lee and Peto, 1970) , and it seemed worth while to undertake a large and well controlled animal experiment to answer the question. Doll (197 1b) predicted that it should be possible to decide this issue definitively. The e*periment described in the present paper goes a long way towards doing this.
MATERIALS AND METHODS
Mice and details of treatment.-The experiment was carried out in a closed animal unit under barrier conditions. Nine hundred and fifty female mice of a random-bred Swiss albino strain born in one part of the unit were, at the age of 5 (+ 1) weeks, transferred to a room in another part of the unit set aside for the experiment. At this time they were randomly allocated to groups 1, 2, 3 or 4, which consisted respectively of 140, 170, 220 and 420 mice. They were housed in macralon boxes, 10 per box, given autoclaved wood shavings as bedding, and provided ad libitum with water and an autoclaved vitamin fortified diet based on the 41B formula (supplied by Spillers Ltd).
The normal lifespan of such mice in these conditions is 2-3 years.
At the age of 10 weeks, and at weeklv intervals thereafter, the backs of the 140 When animals died or were killed, lumps of any size in the subcutaneous tissues in the shaved area were taken for histological examination, in addition to 10 mm lumps apparently arising from the skin surface. Many of the subcutaneous lumps proved to be sarcomata and none w%vere 10 mm epithelial tumours. However, 9 out of the total of 500 10 mm lumps wNhich appeared to be arising from the epithelium were not, in fact, epithelial tumours: 8 were sarcomata and one was an ulcerating cyst associated with a malignant lymphoma.
Statistical analysis. Because the observed incidence of news tumours during a particular fortnight may well be, for example, only 2/100, which is so small that it is unstable, we need some stable way of displaying the incidence rates in each of the 4 groups so that the overall pattern is not lost in random variation. The cumulative incidence" (Peto, 1974) Although the main interest of the experiment was in the qualitative dependence of incidence on duration of treatment and on age given duration of treatment, a quantitative comparison between Group 1, which started regular treatment at 10 wreeks of age, and Group 4, which started regular treatment at 55 weeks of age, was performed using methods appropriate for ' non-incidental " tumours (Peto, 1974) .
It made no material difference to the results of our analysis whether we compared "time to first 2 mm epithelial tumour", "time to first 6 mm epithelial tumour" or "' time to first 10 mm epithelial tumour" in the 4 groups. Of these analyses, " time to first 10 mm epithelial tumour" seemed the most biologically relevant, since a greater proportion of the 2 mm and 6 mm tumours were benign, and so this is the only one reported in detail.
Since tumours were " charted " only once every fortnight, if a tumour reached 10 mm between 2 chartings it would not be recorded as having done so until the second charting. Time is therefore divided into fortnights and we only know that 10 mm tumours detected at the end of a fortnight reached 10 mm at some time during that fortnight. The sizes of skin tumours in mice which died or were killed between chartings were measured and it was assumed that mice which died in the first half of the fortnight without 10 mm tumours had not been mice which died in the second half had been. In a few mice more than one skin tumour grew to a diameter of 10 mm or more during one fortnight. In these cases the animal was categorized using only the most malignant of its 10 mm skin tumours. Sections were obtained from all 10 mm tumours without exception, but sections from 10 of these tumours were lost. All 10 were, from the description of their appearance in vivo, epithelial tumours and have been assumed to be such in the presentation and analysis of the results.
RESULTS
Histology of 10 mm epithelial tumours Almost all of these epithelial tumours were malignant: of the 481 from which sections reached the histologist, 427 (89%) showed infiltration of the panniculus muscle and in the opinion of the pathologist (FJCR) a further 42 (9%) were also malignant since they showed invasion of the dermal tissues, although not of the panniculus muscle. There would be no disagreement among pathologists about the malignant nature of the tumours which showed invasion of the panniculus, but the malignant status of some of the other tumours might be disputed. We therefore concluded only that over 90 % of the 10 mm epithelial tumours were unequivocally malignant.
There was no difference between the 4 treatment groups in the proportions of 10 mm tumours which showed infiltration of muscle (Table II) and so our analysis would yield similar results even if we had restricted our interest still further to only those 10 mm epithelial tumours which were infiltrating the panniculus muscle.
Comparison of Hypotheses 1 and 2 for incidence rates of 10 mm epithelial tumours If benzpyrene acts on the first stage of the progression of normal cells towards malignancy, we would expect very different results under Hypotheses 1 and 2 if we plotted the life tables for the 4 treatment groups against age and then against duration of exposure. Figure 1 displays the expected pattern of results under Hypothesis 2 (in which incidence rate depends wholly on treatment duration and, given this, not at all on age) and under the most extreme version of Hypothesis 1 (in which incidence rate depends wholly on age and, given this, not at all on treatment duration); the actual results are set out in Fig. 2 . The complete data from which Fig. 2 was derived are set out in the Appendix. It is clear that the extreme version of Hypothesis 1 is completely untenable: the increased rate of production of tumours after prolonged exposure to benzpyrene cannot plausibly be attributed to mice becoming more susceptible to benzpyrene as they grow older. Hypothesis 2 is extremely plausible, however: the response of mouse skin to benzpyrene can be explained very satisfactorily in terms of duration of exposure. There is in fact no indication at all of age having any substantial effect after duration of treatment is taken into account. The actual numbers of 10 mm epithelial tumours observed in the 4 groups are (Peto and Pike, 1973) , the difference between Groups 1 and 4 in time from starting BP to developing a tumour is not statistically significant (P > 10%). The incidence in the older mice was, in fact, slightly but not significantly lower than in the younger mice with a similar duration of BP exposure.
Comparison of Hypotheses 1 and 2 for tumour growth rates from 2 mm to 10 mm Another way in which ageing tissue might differ from younger tissue is in the rate at which established tumours grow. In laboratory animals exposed to carcinogens, it is commonly true that the tumours which arise early grow more rapidly than those that arise later. A possible explanation is that faster growth seen after a tumour has reached a detectable size is matched by faster growth from the time of induction to detectable size, i.e. rapid growth caused early appearance. Alternatively, the growth rates of tumours originating in ageing tissues might be essentially slower. The present experiment enables us to test these possible explanations, since we are able to compare the times taken to grow from 2 mm to 10 mm by tumours which reached 10 mm after similar durations of exposure to BP in mice whose ages differed by up to a year. We find, as expected, that the mean time since a 10 mm epithelial tumour was 2 mm is shorter for the 10 mm tumours which arose earliest after the start of treatment; the regression of " time since 2 mm" on "treatment duration at 10 mm" in weeks is 10 + (duration -70.4) x 0419, the standard error of the regression coefficient 0419 being ±0-02 and the standard deviation of (actualpredicted) growth times being ± 55 weeks. However, it is not true that tumours which arise after similar durations of painting grow faster in younger animals; the simultaneous regression coefficients of " time since 2 mm " on " treatment duration at 10 mm " and " age at 10 mm " are 04190 ± 0-022 and 0-006 ± 0-013. In summary, growth rates, like incidence rates, depend on duration of exposure to benzpyrene (the most rapidly growing tumours tending to be detected sooner) but not at all on age given duration of exposure.
Test of the power-law increase of incidence rates with duration of exposure Since our aim in this experiment was to compare various explanations for the observed power-law increase with age of many human adult cancer rates (in which the incidence rate during adult life is approximately a power of age), we must check that our data exhibit, at least approximately, a power-law increase of cancer incidence rates with duration of exposure.
In the human situation, where the period of growth of a tumour may sometimes be onlv a small fraction of the duration of exposure, it may be reasonable under the local multistage hypothesis to expect a reasonably exact fit to this relationship. However, the situation in our experiment on mice is somewhat different.
We know that the time taken for tumours to grow from 2 mm diameter (about 106 cells) to 10 mm diameter (about 108 cells) is, on average, about 6 weeks for tumours arising after 50 weeks of BP treatment, about 10 weeks for tumours arising after 70 weeks of BP treatment and about 14 weeks for tumours arising after 90 weeks of treatment. In other words, a 100-fold increase in the numbers of cells is taking of order 2 or 3 months to complete. How long, on average, has the growth from a single malignant cell to a 10 mm tumour taken? This question cannot be answered directly but it seems unlikely to be less than 6 months and may well be considerably more, since the transition from a single cell to a 2 mm tumour requires three 100-fold increases and (since the one observable 100-fold increase takes 2 or 3 months) these three 100-fold in creases will presumably take at least 4 months to complete.
Because of this delay, we would not expect the age-specific incidence rate of the first tiny clones of malignant cells to be exactly reflected in the age-specific incidence rate of 10 mm epithelial tumours. Moreover, random variation in these delays will make the increase of the incidence rate of 10 mm tumours with exposure duration shallower than the increase of the incidence rate of first clones with exposure duration.
Despite these reservations, we have plotted, for each fortnightly charting, the percentage incidence of 10 mm epithelial tumours observed at that charting on a logarithmic scale against duration of BP exposure minus 61 months (the value which generated the straightest line), pooling all the data from Groups 1-4. The results of this are shown in Fig. 3 , and it is obvious that over the 100-fold range from 0 25% per fortnight up to the massive incidence rate of 25% per fortnight observed after 90 We do not know whether these differences were associate(1 with differences in the amounts of food consumed. It is concluded that although differences in growth might have slightly influenced the tumour crops detected, the effect is unlikely to have been enouigh to affect our qualitative conclusions.
Sa rcomata
A total of 44 of the .950 mice in the experiment developed sarcomata arising in the subcutaneous tissues (I mouse in Group 1, 3 in Group 2, 10 in Group 3 and 30 in Group 4, between weeks 69 and 121 of age-see Appendix). The sarcoma incidence rate was found to depend on age but, given age, not on the duration of BP treatment (X32 comparing age-specific sarcoma incidence rates in the 4 groups 0.4, indicating no heterogeneity). This result could be explained theoretically in one of 2 ways: either BP has no effect on sarcoma iincidence at all or BP affects only the final stage of the carcinogenic process, while the earlier stages are brought about by influences other than BP. From our experimental results alone, it is not possible to discriminate between these 2 possibilities as there was no untreated control group. In previous skin-painting experiments (e.g. Roe et al., 1970) , female Swiss mice exposed only to acetone experienced age-specific incidence rates of the same order as in the present experiment. It seems likely therefore that BP has no, or at most a very small, effect on sarcoma incidence. As with human sarcomata, the incidence rate of sarcomata in our experiment increased less steeply with time than did the incidence rates of epithelial tumotirs.
DISCUSSION
We have applied a carcinogen to the skin of mice up to the extremes of old age (i.e. 2-3 years) and have observed that the skin cancer incidence rates depenid only on duration of carcinogenic inisuilt and, givein this dturatioin, nlot at all on the age of the animals when regular exposure to the insult began (which was 10, 25, 40 or 55 weeks). These results can be completely explained by the local multistage model with no intrinsic effect of age. Although it is possible that an intrinsic effect of ageing was obscured by opposing age-related changes in metabolic activation, deactivation or clearance rates, hair growth cycles and so on which are peculiar to our experiment and which would not necessarily be relevant to other carcinogens, to other species or to target tissues other than the skin, there is no positive reason to suppose that any such biases have occurred.
Comparison with other experimental findings
A result which apparently contradicts our findings has been reported by Ebbesen (1973 Ebbesen ( , 1974 , who studied DMBA induced carcinomata in mouse skin of different ages transplanted on to syngeneic hosts of the same age. Although the experimental methods were not reported in sufficient detail to allow proper evaluation of the results, it appears that the older the skin at the time of transplant, the more susceptible it was to subsequent tumour induction. Like us, Ebbesen compared the incidence of skin carcinomata in skin aged 1-2 years with the incidence in skin aged 2-3 years, but his carcinogenic stimulus was weaker than ours (2 isolated DMBA applications resulting in only 10% or so of the animals developing carcinomata) and it may be that our stronger stimulus swamped the spontaneous mutations in the stem cells of the skin whereas his weaker stimulus did not. In any case, his results can be explained naturally under Hypothesis 2 while our results cannot under Hypothesis 1.
However, this explanation raises rather a delicate point. In our experiment, as in Ebbesen's experiment, carcinogens are applied to tissues of different ages to discover whether, apart from the accumnulation with time of heritable changes in particular cells, age has any other relevance to carcinogensis. If no difference is observed, as in our experiment, that is evidence that age has no other relevance and that the spontaneous rates of each stage were swamped by the carcinogen induced rates of those stages. If, however, the older animals are more vulnerable, as in Ebbesen's experiment, this can be interpreted as evidence that the spontaneous accumulation of certain stages with time is sufficient not to be swamped by the carcinogen and that although no other effect of age is relevant, this accumulation is sufficient to generate an appreciable difference in vulnerability. Can the hypothesis of " no other relevance of age" (Hypothesis 2) ever be contradicted by any conceivable result? It can, but not by applying carcinogens to tissues of different ages, as we have done; our experiment can only contradict Hypothesis 1. A critical experiment for Hypothesis 2 is to apply carcinogens to tissues of the same age transplanted into hosts of different ages, but as far as we know no such experiment has ever been reported.
Another result like Ebbesen's is that of Berry and Wagner (1975) , who have examined the induction of rat mesotheliomata by a single intrapleural instillation of asbestos at either 2 or 10 months of age. If it is assumed that the asbestos is not eliminated, this constitutes a continuous carcinogenic stimulus, starting at the time of the instillation and continuing until death and it appears, on preliminary inspection of their data, that the group treated later in life developed mesotheliomata more rapidly after the instillation than did the other group. Again, however, this can be explained under Hypothesis 2 by assuming that some of the stages occurred spontaneously to an appreciable extent between months 2 and 10. The experiment of Van Duuren et al. (1975) on 561 mice may represent a third such result, but unfortunately failure to use life-tables in describing their findings makes it impossible to discover whether any age-related differences in tumour inducibility existed.
Finally, Meranze et al. (1969) may have found one genuine age-related change in tumour inducibility. 15 mg of intragastric DMBA results in more mammary tumours in female rats if given at about 6 weeks of age than if given at about 26 weeks of age, even if differences in subsequent duration of exposure are properly allowed for. This may be due to agerelated hormonal changes which selectively affect mammary tissue, as in adult human females. However, DMBA in such enormous doses has many other systemic effects, particularly on hormonal status, and it may be these rather than any more direct carcinogenic effects which are responsible. Moreover, the dose in mg per kg body weight was, of course, less than half as big in their older animals, and it is also possible that all Meranze et al. observed was an age related change in the effective dose to the target organ.*
Conclusions
Notwithstanding these doubts, our results certainly show that a power law increase of incidence with duration of exposure can arise in the absence of any intrinsic effects of age such as, for example, decreasing efficiency of immunological surveillance. (Some independent evidence against the influence, age dependent or otherwise, of immunological surveillance on cancer incidence already exists, in that Rygaard and Povlsen (1974) Han/an expossure at different ages Under almost any hypothesis, lifelong regular exposure of humans to a carcinogenic insult will be more dangerous the younger exposure starts. There is, however, disagreement as to whether brief exposure is more dangerous for the young or for the old. Our results suggest that although the immediate risk to old people may be greater, the total subsequent effect of brief exposure to a carcinogenic insult will eventually be worse in people exposed when young. (This might not be true for a brief insult which merely " promotes " and cannot ' initiate ", but conversely an insult which merely initiates and cannot promote would be enormously more dangerous for people who were exposed to it when young.)
An utnresolved difficulty
We have shown that the lapse of an extra year of age before starting treatment (more than one-third of the life span) does not increase the susceptibility of mouse skin to benzpyrene carcinogenesis, nor does it increase the rate of growth of such tumours once they are established. Previous work (Lee and O'Neill, 1971) has shown that in this system the age specific incidence rate is proportional to the square of the dose rate of benzpyrene and it can be shown that utnder a simple hypothesis such as that of Armitage and Doll (1961) A diploid cell has 2 loci that code for each enzyme, one on each of a pair of homologous chromosomes. If inactivation of such an enzyme is required during carcinogenesis, this must occur in 2 stages. In the first stage, the carcinogen effects a destructive mutation in one of the loci, converting the cell from AA to AA (A being inactive). The second stage might then take place not by a second destructive mutation but rather by " mitotic recombination ", a rare error whereby mitosis results in AA and AA instead of 2 AA daughters. This provides a natural mechanism whereby no exogenous carcinogen is required to bring about some of the stages. However, although such a sequence of events could explain the third-power dependence of cancer incidence on duration of exposure observed when benzpyrene is applied to mouse skin, it is difficult to see how it alone could lead to the fifthand sixth-power dependence on duration sometimes observed in man, especially since, in the most extensively studied human situation (the association between cigarette smoking and lung cancer), the cancer incidence rate appears to increase only as a single power of dose. The fact that chronic exposuire to a carcinogen leads to an incidence rate of cancer which depends far more strongly on duration of exposure than oIn dose rate is one of the most important unexplained features of the aetiology of cancer in adults.
A possible non-causal link between ageing and cancer incidence
We have concluded that during normal life, random heritable changes may occur by accident in particular stem cells and that when certain such changes all happen in a single stem cell the result may be proliferation into a recognizable cancer. However, of all the heritable changes that might occur in a stem cell, the majority will presumably be irrelevant to carcinogenesis and so, ignoring lethal changes which would eliminate a cell line, in old age several stem cells must have suffered many non-lethal heritable changes by the same general mechanisms that are involved in carcinogenesis. Burnet (1974) has suggested that this accumulation of somatic changes is the fundamental process of ageing, and that the rate at which they occur is subject to evolutionary control (perhaps by inter-species differences in the efficiency of the DNA repair enzymes) and largely determines the typical lifespan of each species. These evolved controls on the rates at which random heritable changes arise in the stem cells of an organism would presumably affect not only the timespan of ageing, but also that of carcinogenesis. If this is so, then the rate of generation of somatic mutations determines both the rate of ageing and the age specific incidence rate of cancer. This postulated common cause for ageing rates and for cancer incidence rates might be the reason why most species suffer some cancer of old age, whether old age occurs at 80 weeks or 80 years, even though ageing itself does not affect oncogenesis. t Lived without 10 mm tumour to end of experiment at treatment week 118.
a Weeks 34, 36 of benzpyrene. b Weeks 14, 14, 18, 22, 36, 36, 38, 38. 30 Notes added in proof
(1) At any given age, there were no systematic differences between the four groups in their death rates from causes other than 10 mm epithelial tumours. (The logrank chi-square for trend between the four groups in mortality from such causes was 0.00, showing no trend whatever.) This suggests that animals only died of treatment via the induction of epithelial tumours, and supports our belief that there was no tendency to die of epithelial tumours before they reached 10 mm.
(One would expect, in an inbred strain, little heterogeneity in susceptibility to ageing or to carcinogenesis, and hence no appreciable within-strain correlation between these two susceptibilities. This expectation is also supported by the above null trend.) (2) Had a Weibull distribution been fitted to these data by maximum likelihood, as suggested by Peto and Lee (1973) , the absolute values of the parameters k and w would have been unduly influenced by the single tumourless survivor in group 2, and still more by the early tumour in group 4. This emphasizes the importance of comparing Weibull b-parameters by Cox's method whenever possible (ibid., p. 468). (3) It has been suggested that heritable changes affecting DNA repair enzymes might accumulate with age, and that when sufficient such changes have accumulated, successful cell division is unlikely. This postulated process (or a modified version of it in which the DNA repair enzymes are so damaged that further damage to the DNA coding for these enzymes then occurs rapidly) is referred to as " error catastrophe ". It has been suggested that error catastrophe is responsible for tissue ageing, and that it is responsible for the increased cancer incidence rates among old individuals. As we have described error catastrophe, changes in one cell only affect its own descendants and error catastrophe is merely a particular example of our " local multistage model " in which the early stage(s) affect the repair enzymes. If, implausibly, some form of change which would affect DNA repair in all the cells in a tissue similarly were postulated, then older tissues would be essentially more vulnerable to carcinogens in a manner which has been contradicted by our experiment.
